| 1 |
Controlled release of rasagiline mesylate promotes neuroprotection in a rotenone-induced advanced model of Parkinsonęs disease |
|
|
| FernƔndez, M. and Barcia, E. and FernƔndez-Carballido, A. and Garcia, L. and Slowing, K. and Negro, S. |
|
| International Journal of Pharmaceutics. 2012; 438(1-2): 266-278 |
|
| [Pubmed] [Google Scholar] |
|
| 2 |
Recent updates in redox regulation and free radical scavenging effects by herbal products in experimental models of parkinsonęs disease |
|
|
| Koppula, S. and Kumar, H. and More, S.V. and Lim, H.-W. and Hong, S.-M. and Choi, D.-K. |
|
| Molecules. 2012; 17(10): 11391-11420 |
|
| [Pubmed] [Google Scholar] |
|
| 3 |
Nutraceuticals and their preventive or potential therapeutic value in Parkinsonęs disease |
|
|
| Chao, J. and Leung, Y. and Wang, M. and Chang, R.C.-C. |
|
| Nutrition Reviews. 2012; 70(7): 373-386 |
|
| [Pubmed] [Google Scholar] |
|
| 4 |
In vitro antioxidant and anti-arthritic activities of Shilajit |
|
|
| Rege, A. and Juvekar, P. and Juvekar, A. |
|
| International Journal of Pharmacy and Pharmaceutical Sciences. 2012; 4(2): 650-653 |
|
| [Pubmed] [Google Scholar] |
|
| 5 |
Protein oxidation: A potential cause of hypoalbuminemia in oral cancer |
|
|
| Chandran, V. and Anitha, M. and Avinash, S.S. and Rao, G.M. and Shetty, B.V. and Sudha, K. |
|
| Biomedical Research. 2012; 23(2): 227-230 |
|
| [Pubmed] [Google Scholar] |
|
| 6 |
An effective novel delivery strategy of rasagiline for Parkinsonęs disease |
|
|
| FernƔndez, M. and Negro, S. and Slowing, K. and FernƔndez-Carballido, A. and Barcia, E. |
|
| International Journal of Pharmaceutics. 2011; 419(1-2): 271-280 |
|
| [Pubmed] [Google Scholar] |
|
| 7 |
Peripheral markers for oxidative stress in Parkinsonęs disease patients of Eastern India |
|
|
| Sanyal, J. and Sarkar, B. and Banerjee, T.K. and Mukherjee, S.C. and Ray, B.C. and Rao, V.R. |
|
| Neurochemical Journal. 2011; 5(2): 146-149 |
|
| [Pubmed] [Google Scholar] |
|
| 8 |
Influence of ionizing radiation and conventional food processing treatments on the status of free radicals in lotus seeds: An ESR study |
|
|
| Bhat, R. and Sridhar, K.R. |
|
| Journal of Food Composition and Analysis. 2011; 24(4-5): 563-567 |
|
| [Pubmed] [Google Scholar] |
|
| 9 |
Study of telomere length and different markers of oxidative stress in patients with Parkinsonęs disease |
|
|
| Watfa, G. and Dragonas, C. and Brosche, T. and Dittrich, R. and Sieber, C.C. and Alecu, C. and Benetos, A. and Nzietchueng, R. |
|
| Journal of Nutrition, Health and Aging. 2011; 15(4): 277-281 |
|
| [Pubmed] [Google Scholar] |
|
| 10 |
Effects of structural analogues of nociceptin(1-13)NH 2 on brain antioxidant status in kainic acid-treated rats |
|
|
| Tzvetanova, E. and Nenkova, G. and Georgieva, A. and Alexandrova, A. and Girchev, R. and Kirkova, M. |
|
| Cell Biochemistry and Function. 2011; 29(2): 135-141 |
|
| [Pubmed] [Google Scholar] |
|
| 11 |
Case-control studies on ceruloplasmin and superoxide dismutase (SOD1) in neurodegenerative diseases: A short review |
|
|
| Torsdottir, G. and Kristinsson, J. and Snaedal, J. and SveinbjƶrnsdĆ³ttir, S. and Gudmundsson, G. and Hreidarsson, S. and JĆ³hannesson, T. |
|
| Journal of the Neurological Sciences. 2010; 299(1-2): 51-54 |
|
| [Pubmed] [Google Scholar] |
|
| 12 |
The role of oxidative stress in amyotrophic lateral sclerosis and Parkinsonęs disease |
|
|
| Baillet, A. and Chanteperdrix, V. and TrocmƩ, C. and Casez, P. and Garrel, C. and Besson, G. |
|
| Neurochemical Research. 2010; 35(10): 1530-1537 |
|
| [Pubmed] [Google Scholar] |
|
| 13 |
Synthesis and evaluation of antioxidant activities of some indole-2,3-dione derivatives and analogs |
|
|
| Prakash, C.R. and Panneerselvam, T. and Raja, S. |
|
| Toxicological and Environmental Chemistry. 2010; 92(8): 1397-1407 |
|
| [Pubmed] [Google Scholar] |
|
| 14 |
Plasma levels of lipid peroxides in patients with Parkinsonęs disease |
|
|
| Sanyal, J., Bandyopadhyay, S.K., Banerjee, T.K., Mukherjee, S.C., Chakraborty, D.P., Ray, B.C., Rao, V.R. |
|
| European Review for Medical and Pharmacological Sciences. 2009; 13(2): 1-2 |
|
| [Pubmed] [Google Scholar] |
|
| 15 |
Synthesis of some N-substituted nitroimidazole derivatives as potential antioxidant and antifungal agents |
|
|
| Olender, D., Zwawiak, J., Lukianchuk, V., Lesyk, R., Kropacz, A., Fojutowski, A., Zaprutko, L. |
|
| European Journal of Medicinal Chemistry. 2009; 44(2): 1-2 |
|
| [Pubmed] [Google Scholar] |
|
| 16 |
Study of the cytotoxicity and antioxidant capacity of N/OFQ(1-13)NH 2 and its structural analogues |
|
|
| Kirkova, M., Zamfirova, R., Leśkiewicz, M., Kubera, M., Lasoń, W., Todorov, S. |
|
| Pharmacological Reports. 2009; 61(6): 1-2 |
|
| [Pubmed] [Google Scholar] |
|
| 17 |
Are nociceptin(1-13)NH2 and its structural analogue [ORN9]nociceptin(1-13)NH2 able to affect brain antioxidant status in control and kainic acid-treated rats? |
|
|
| Tzvetanova, E., Pavlova, A., Alexandrova, A., Nenkova, G., Petrov, L., Kirkova, M., Girchev, R., Naydenova, E. |
|
| Cell Biochemistry and Function. 2009; 27(4): 1-2 |
|
| [Pubmed] [Google Scholar] |
|
| 18 |
Determination of an antioxidant capacity index by immobilized tyrosinase bioreactor |
|
|
| Girelli, A.M., Giuliani, T., Mattei, E., Papaleo, D. |
|
| Journal of Agricultural and Food Chemistry. 2009; 57(12): 1-2 |
|
| [Pubmed] [Google Scholar] |
|
| 19 |
Antioxidant supplements in management of Parkinsonęs disease |
|
|
| Ribarova, F., Stoimenova, A., Popova, K. |
|
| Archives of the Balkan Medical Union. 2009; 44(2): 1-2 |
|
| [Pubmed] [Google Scholar] |
|
| 20 |
Increased oxidative damage in peripheral blood correlates with severity of Parkinsonęs disease |
|
|
| Chen, C.-M., Liu, J.-L., Wu, Y.-R., Chen, Y.-C., Cheng, H.-S., Cheng, M.-L., Chiu, D.T.-y. |
|
| Neurobiology of Disease. 2009; 33(3): 1-2 |
|
| [Pubmed] [Google Scholar] |
|
| 21 |
Effect of resistance training on blood oxidative stress in Parkinson disease |
|
|
| Bloomer, R.J., Schilling, B.K., Karlage, R.E., Ledoux, M.S., Pfeiffer, R.F., Callegari, J. |
|
| Medicine and Science in Sports and Exercise. 2008; 40(8): 1-2 |
|
| [Pubmed] [Google Scholar] |
|
| 22 |
Statin adverse effects: A review of the literature and evidence for a mitochondrial mechanism |
|
|
| Golomb, B.A., Evans, M.A. |
|
| American Journal of Cardiovascular Drugs. 2008; 8(6): 1-2 |
|
| [Pubmed] [Google Scholar] |
|
| 23 |
Immunomodulatory and antioxidant activity of a polyherbal formulation |
|
|
| Meera, S., Gupta Atyam, V.S.S.S., Kumar, N.S. |
|
| International Journal of Pharmacology. 2008; 4(4): 1-2 |
|
| [Pubmed] [Google Scholar] |
|
| 24 |
Oxidative stress mediated electrolyte imbalance in Parkinsonęs disease |
|
|
| Saxena, R., Jaiswal, G., Lal, A.M., Sarkar, S. |
|
| Biomedicine. 2008; 28(1): 1-2 |
|
| [Pubmed] [Google Scholar] |
|
| 25 |
Advances in the treatment of Parkinsonęs disease |
|
|
| Singh, N., Pillay, V., Choonara, Y.E. |
|
| Progress in Neurobiology. 2007; 81(1): 29-44 |
|
| [Pubmed] [Google Scholar] |
|
| 26 |
Peripheral blood markers of oxidative stress in Parkinsonęs disease |
|
|
| Younes-Mhenni, S., Frih-Ayed, M., Kerkeni, A., Bost, M., Chazot, G. |
|
| European Neurology. 2007; 58(2): 78-83 |
|
| [Pubmed] [Google Scholar] |
|
| 27 |
Total antioxidant activity in Parkinsonęs disease |
|
|
| Adiga, U., DęSouza, J., Kousalya, R., Rao, G.M., Nandini, M., DęSouza, V. |
|
| Biomedical Research. 2006; 17(2): 145-147 |
|
| [Pubmed] [Google Scholar] |
|
| 28 |
Evaluation of Pluchea carolinensis extracts as antioxidants by the epinephrine oxidation method |
|
|
| Evaluation of Pluchea carolinensis extracts as antioxidants by the epinephrine oxidation method |
|
| Fitoterapia. 2006; 77(3): 221-226 |
|
| [Pubmed] [Google Scholar] |
|
| 29 |
Reactive intermediates and the pathogenesis of adverse drug reactions: The toxicology perspective |
|
|
| Amacher, D.E. |
|
| Current Drug Metabolism. 2006; 7(3): 219-229 |
|
| [Pubmed] [Google Scholar] |
|
| 30 |
Ceruloplasmin and superoxide dismutase (SOD1) in Parkinsonęs disease: A follow-up study |
|
|
| Tórsdóttir, G., Sveinbjörnsdóttir, S., Kristinsson, J., Snaedal, J., Jóhannesson, T. |
|
| Journal of the Neurological Sciences. 2006; 241(1-2): 53-58 |
|
| [Pubmed] [Google Scholar] |
|
| 31 |
Kynurenine metabolism in plasma and in red blood cells in Parkinsonęs disease |
|
|
| Hartai, Z., Klivenyi, P., Janaky, T., Penke, B., Dux, L., Vecsei, L. |
|
| Journal of the Neurological Sciences. 2005; 239(1): 31-35 |
|
| [Pubmed] [Google Scholar] |
|
| 32 |
Erythrocyte antioxidant enzymes in Parkinsonęs disease |
|
|
| Abraham, S., Soundararajan, C.C., Vivekanandhan, S., Behari, M. |
|
| Indian Journal of Medical Research. 2005; 121(2): 111-115 |
|
| [Pubmed] [Google Scholar] |
|
| 33 |
Neuroprotection by crocetin in a hemi-parkinsonian rat model |
|
|
| Ahmad, A.S., Ansari, M.A., Ahmad, M., Saleem, S., Yousuf, S., Hoda, Md.N., Islam, F. |
|
| Pharmacology Biochemistry and Behavior. 2005; 81(4): 805-813 |
|
| [Pubmed] [Google Scholar] |
|
| 34 |
Oxidative damage and plasma antioxidants in cerebrovascular accident |
|
|
| Sudha, K., Rao, A.V., Rao, S.N., Rao, A. |
|
| Indian Journal of Physiology and Pharmacology. 2004; 48(4): 489-492 |
|
| [Pubmed] [Google Scholar] |
|
